These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 8561954)

  • 21. Central serotonin(2B) receptor blockade inhibits cocaine-induced hyperlocomotion independently of changes of subcortical dopamine outflow.
    Devroye C; Cathala A; Di Marco B; Caraci F; Drago F; Piazza PV; Spampinato U
    Neuropharmacology; 2015 Oct; 97():329-37. PubMed ID: 26116760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of dopamine D3 receptors in controlling the expression of cocaine sensitization in rats.
    Filip M; Papla I; Czepiel K
    Pol J Pharmacol; 2002; 54(6):687-91. PubMed ID: 12866725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of novel, potent, and selective dopamine reuptake inhibitors through alteration of the piperazine ring of 1-[2-(diphenylmethoxy)ethyl]-and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909).
    Matecka D; Rothman RB; Radesca L; de Costa BR; Dersch CM; Partilla JS; Pert A; Glowa JR; Wojnicki FH; Rice KC
    J Med Chem; 1996 Nov; 39(24):4704-16. PubMed ID: 8941383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of 2beta-propanoyl-3beta-(4-tolyl)-tropane (PTT) on the self-administration of cocaine, heroin, and cocaine/heroin combinations in rats.
    Sizemore GM; Davies HM; Martin TJ; Smith JE
    Drug Alcohol Depend; 2004 Mar; 73(3):259-65. PubMed ID: 15036548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medications for stimulant abuse: agonist-based strategies and preclinical evaluation of the mixed-action D-sub-2 partial agonist aripiprazole (Abilify).
    Bergman J
    Exp Clin Psychopharmacol; 2008 Dec; 16(6):475-83. PubMed ID: 19086768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Behavioral effects of cocaine: interactions with D1 dopaminergic antagonists and agonists in mice and squirrel monkeys.
    Katz JL; Kopajtic TA; Myers KA; Mitkus RJ; Chider M
    J Pharmacol Exp Ther; 1999 Oct; 291(1):265-79. PubMed ID: 10490913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and pharmacological evaluation of potent and highly selective D3 receptor ligands: inhibition of cocaine-seeking behavior and the role of dopamine D3/D2 receptors.
    Campiani G; Butini S; Trotta F; Fattorusso C; Catalanotti B; Aiello F; Gemma S; Nacci V; Novellino E; Stark JA; Cagnotto A; Fumagalli E; Carnovali F; Cervo L; Mennini T
    J Med Chem; 2003 Aug; 46(18):3822-39. PubMed ID: 12930145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects.
    Volkow ND; Wang GJ; Fowler JS; Logan J; Gatley SJ; Hitzemann R; Chen AD; Dewey SL; Pappas N
    Nature; 1997 Apr; 386(6627):830-3. PubMed ID: 9126741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective action of an atypical neuroleptic on the mechanisms related to the development of cocaine addiction: a pre-clinical behavioural study.
    Marinho EA; Oliveira-Lima AJ; Wuo-Silva R; Santos R; Baldaia MA; Hollais AW; Longo BM; Berro LF; Frussa-Filho R
    Int J Neuropsychopharmacol; 2014 Apr; 17(4):613-23. PubMed ID: 24345415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamics of extracellular dopamine in the acute and chronic actions of cocaine.
    Bradberry CW
    Neuroscientist; 2002 Aug; 8(4):315-22. PubMed ID: 12194500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential regulation of dopamine transporter after chronic self-administration of bupropion and nomifensine.
    Tella SR; Ladenheim B; Cadet JL
    J Pharmacol Exp Ther; 1997 Apr; 281(1):508-13. PubMed ID: 9103538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonin2C receptors modulate dopamine transmission in the nucleus accumbens independently of dopamine release: behavioral, neurochemical and molecular studies with cocaine.
    Cathala A; Devroye C; Maitre M; Piazza PV; Abrous DN; Revest JM; Spampinato U
    Addict Biol; 2015 May; 20(3):445-57. PubMed ID: 24661380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High affinity dopamine reuptake inhibitors as potential cocaine antagonists: a strategy for drug development.
    Rothman RB
    Life Sci; 1990; 46(20):PL17-21. PubMed ID: 2111866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance enhancing, non-prescription use of Ritalin: a comparison with amphetamines and cocaine.
    Svetlov SI; Kobeissy FH; Gold MS
    J Addict Dis; 2007; 26(4):1-6. PubMed ID: 18032226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.
    Broderick PA; Hope O; Okonji C; Rahni DN; Zhou Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):157-71. PubMed ID: 14687870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypothesis-driven medication discovery for the treatment of psychostimulant addiction.
    Xi ZX; Gardner EL
    Curr Drug Abuse Rev; 2008 Nov; 1(3):303-27. PubMed ID: 19430578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of the effects of dopaminergic agents in humans: implications for medication development.
    Rothman RB
    NIDA Res Monogr; 1994; 145():67-87. PubMed ID: 8742808
    [No Abstract]   [Full Text] [Related]  

  • 38. Interactions of cocaine with dopamine uptake inhibitors or dopamine releasers in rats discriminating cocaine.
    Li SM; Campbell BL; Katz JL
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1088-96. PubMed ID: 16478825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopaminergic responses to self-administered cocaine in Rhesus monkeys do not sensitize following high cumulative intake.
    Bradberry CW; Rubino SR
    Eur J Neurosci; 2006 May; 23(10):2773-8. PubMed ID: 16817880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cocaine- and amphetamine-regulated transcript peptides play a role in drug abuse and are potential therapeutic targets.
    Kuhar MJ; Jaworski JN; Hubert GW; Philpot KB; Dominguez G
    AAPS J; 2005 Sep; 7(1):E259-65. PubMed ID: 16146347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.